Global Alzheimer Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Alzheimer Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cholinergic
      • 1.4.3 Memantine
      • 1.4.4 Combined Drug
    • 1.5 Market by Application
      • 1.5.1 Global Alzheimer Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacy
      • 1.5.3 Retail Pharmacy
      • 1.5.4 Online Sales
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Alzheimer Market Size
    • 2.2 Alzheimer Growth Trends by Regions
      • 2.2.1 Alzheimer Market Size by Regions (2014-2025)
      • 2.2.2 Alzheimer Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Alzheimer Market Size by Manufacturers
      • 3.1.1 Global Alzheimer Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Alzheimer Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Alzheimer Market Concentration Ratio (CR5 and HHI)
    • 3.2 Alzheimer Key Players Head office and Area Served
    • 3.3 Key Players Alzheimer Product/Solution/Service
    • 3.4 Date of Enter into Alzheimer Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Alzheimer Market Size by Type (2014-2019)
    • 4.2 Global Alzheimer Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Alzheimer Market Size (2014-2019)
    • 5.2 Alzheimer Key Players in United States
    • 5.3 United States Alzheimer Market Size by Type
    • 5.4 United States Alzheimer Market Size by Application

    6 Europe

    • 6.1 Europe Alzheimer Market Size (2014-2019)
    • 6.2 Alzheimer Key Players in Europe
    • 6.3 Europe Alzheimer Market Size by Type
    • 6.4 Europe Alzheimer Market Size by Application

    7 China

    • 7.1 China Alzheimer Market Size (2014-2019)
    • 7.2 Alzheimer Key Players in China
    • 7.3 China Alzheimer Market Size by Type
    • 7.4 China Alzheimer Market Size by Application

    8 Japan

    • 8.1 Japan Alzheimer Market Size (2014-2019)
    • 8.2 Alzheimer Key Players in Japan
    • 8.3 Japan Alzheimer Market Size by Type
    • 8.4 Japan Alzheimer Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Alzheimer Market Size (2014-2019)
    • 9.2 Alzheimer Key Players in Southeast Asia
    • 9.3 Southeast Asia Alzheimer Market Size by Type
    • 9.4 Southeast Asia Alzheimer Market Size by Application

    10 India

    • 10.1 India Alzheimer Market Size (2014-2019)
    • 10.2 Alzheimer Key Players in India
    • 10.3 India Alzheimer Market Size by Type
    • 10.4 India Alzheimer Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Alzheimer Market Size (2014-2019)
    • 11.2 Alzheimer Key Players in Central & South America
    • 11.3 Central & South America Alzheimer Market Size by Type
    • 11.4 Central & South America Alzheimer Market Size by Application

    12 International Players Profiles

    • 12.1 Allergan
      • 12.1.1 Allergan Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Alzheimer Introduction
      • 12.1.4 Allergan Revenue in Alzheimer Business (2014-2019)
      • 12.1.5 Allergan Recent Development
    • 12.2 Eisai
      • 12.2.1 Eisai Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Alzheimer Introduction
      • 12.2.4 Eisai Revenue in Alzheimer Business (2014-2019)
      • 12.2.5 Eisai Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Alzheimer Introduction
      • 12.3.4 Novartis Revenue in Alzheimer Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 Daiichi Sankyo
      • 12.4.1 Daiichi Sankyo Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Alzheimer Introduction
      • 12.4.4 Daiichi Sankyo Revenue in Alzheimer Business (2014-2019)
      • 12.4.5 Daiichi Sankyo Recent Development
    • 12.5 Merz Pharma
      • 12.5.1 Merz Pharma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Alzheimer Introduction
      • 12.5.4 Merz Pharma Revenue in Alzheimer Business (2014-2019)
      • 12.5.5 Merz Pharma Recent Development
    • 12.6 Pfizer
      • 12.6.1 Pfizer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Alzheimer Introduction
      • 12.6.4 Pfizer Revenue in Alzheimer Business (2014-2019)
      • 12.6.5 Pfizer Recent Development
    • 12.7 Johnson & Johnson
      • 12.7.1 Johnson & Johnson Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Alzheimer Introduction
      • 12.7.4 Johnson & Johnson Revenue in Alzheimer Business (2014-2019)
      • 12.7.5 Johnson & Johnson Recent Development
    • 12.8 Lundbeck
      • 12.8.1 Lundbeck Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Alzheimer Introduction
      • 12.8.4 Lundbeck Revenue in Alzheimer Business (2014-2019)
      • 12.8.5 Lundbeck Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer'swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
      Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer'swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
      In 2018, the global Alzheimer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Alzheimer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alzheimer development in United States, Europe and China.

      The key players covered in this study
      Allergan 
      Eisai 
      Novartis 
      Daiichi Sankyo 
      Merz Pharma 
      Pfizer 
      Johnson & Johnson 
      Lundbeck

      Market segment by Type, the product can be split into
      Cholinergic
      Memantine
      Combined Drug 

      Market segment by Application, split into
      Hospital Pharmacy
      Retail Pharmacy
      Online Sales

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Alzheimer status, future forecast, growth opportunity, key market and key players.
      To present the Alzheimer development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Alzheimer are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now